These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2792461)

  • 21. Parathyroid hormone and 25-hydroxyvitamin D levels in glucocorticoid-treated patients.
    Slovik DM; Neer RM; Ohman JL; Lowell FC; Clark MB; Segre GV; Potts JT
    Clin Endocrinol (Oxf); 1980 Mar; 12(3):243-8. PubMed ID: 7389155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup.
    Sato S; Ohosone Y; Suwa A; Yasuoka H; Nojima T; Fujii T; Kuwana M; Nakamura K; Mimori T; Hirakata M
    J Rheumatol; 2003 Dec; 30(12):2673-9. PubMed ID: 14719212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria.
    Ohkawa M; Tokunaga S; Nakashima T; Orito M; Hisazumi H
    Br J Urol; 1992 Jun; 69(6):571-6. PubMed ID: 1638340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis.
    Shiraki M; Fukuchi M; Kiriyama T; Okamoto S; Ueno T; Sakamoto H; Nagai T
    J Bone Miner Metab; 2004; 22(4):352-9. PubMed ID: 15221494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.
    Arrabal-Martin M; Poyatos-Andujar A; Cano-García Mdel C; Quesada-Charneco M; Abad-Menor F; Girón Prieto MS; de Haro Muñoz T; Arrabal-Polo MA
    Int Urol Nephrol; 2015 Mar; 47(3):445-9. PubMed ID: 25652872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium supplementation increases bone mass in GH-deficient prepubertal children during GH replacement.
    Zamboni G; Antoniazzi F; Lauriola S; Bertoldo F; Tatò L
    Horm Res; 2006; 65(5):223-30. PubMed ID: 16569932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin D/calcium.
    Ringe JD; Cöster A; Meng T; Schacht E; Umbach R
    Calcif Tissue Int; 1999 Oct; 65(4):337-40. PubMed ID: 10485988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis.
    Orimo H; Shiraki M; Hayashi Y; Hoshino T; Onaya T; Miyazaki S; Kurosawa H; Nakamura T; Ogawa N
    Calcif Tissue Int; 1994 May; 54(5):370-6. PubMed ID: 8062152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome.
    Bak M; Serdaroglu E; Guclu R
    Pediatr Nephrol; 2006 Mar; 21(3):350-4. PubMed ID: 16382319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1-alpha-Hydroxyvitamin D3 treatment decreases bone turnover and modulates calcium-regulating hormones in early postmenopausal women.
    Chen JT; Shiraki M; Hasumi K; Tanaka N; Katase K; Kato T; Hirai Y; Nakamura T; Ogata E
    Bone; 1997 Jun; 20(6):557-62. PubMed ID: 9177871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of alendronate on glucocorticoid-induced osteoporosis in Japanese women with systemic autoimmune diseases: versus alfacalcidol.
    Takeda S; Kaneoka H; Saito T
    Mod Rheumatol; 2008; 18(3):271-6. PubMed ID: 18427724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial.
    Boutsen Y; Jamart J; Esselinckx W; Stoffel M; Devogelaer JP
    Calcif Tissue Int; 1997 Oct; 61(4):266-71. PubMed ID: 9312195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.
    Fujita T; Satomura A; Hidaka M; Ohsawa I; Endo M; Ohi H
    Calcif Tissue Int; 2000 Mar; 66(3):195-9. PubMed ID: 10666494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ultra long-term treatment of senile osteoporosis with 1 alpha-hydroxyvitamin D3.
    Shiraki M; Ito H; Orimo H
    Bone Miner; 1993 Mar; 20(3):223-34. PubMed ID: 8490326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Microdensitometric study of maturation and fragility of the bone in male patients with cerebral palsy--the effect of long-term administration of 1 alpha-hydroxy vitamin D3 and the value of osteocalcin as a marker of bony growth].
    Hayashi Y; Araki K; Morioka N; Kurashige T; Shiraishi T; Ogura H; Tani J
    No To Hattatsu; 1990 May; 22(3):209-15. PubMed ID: 2363958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis.
    Ringe JD; Dorst A; Faber H; Schacht E; Rahlfs VW
    Rheumatol Int; 2004 Mar; 24(2):63-70. PubMed ID: 14513268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis.
    Yonemura K; Kimura M; Miyaji T; Hishida A
    Calcif Tissue Int; 2000 Feb; 66(2):123-8. PubMed ID: 10652960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum immunoreactive parathyroid hormone and 25-hydroxyvitamin D in patients with uremic bone diseases.
    Shen F-H ; Baylink DJ; Sherrard DJ; Shen L; Maloney NA; Wergedal JE
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1009-17. PubMed ID: 1133150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.